Kiora Pharmaceuticals, Inc.
KPRX
$2.50
-$0.08-3.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -54.29% | 100.79% | 3.11% | -116.30% | -86.17% |
| Total Depreciation and Amortization | 599.43% | 169.01% | 75.98% | 20.99% | 121.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,153.81% | -239.62% | 96.92% | 145.04% | -140.04% |
| Change in Net Operating Assets | -116.84% | -97.36% | -19.96% | -11,832.05% | 446.64% |
| Cash from Operations | 3.19% | -238.37% | -1.87% | -119.85% | 12.74% |
| Capital Expenditure | -273.78% | -- | 37.23% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,139.96% | 398.95% | 103.29% | -- | -- |
| Cash from Investing | 1,008.16% | 398.93% | 103.13% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 6.42% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -- | -- | 5.95% | -- | 100.00% |
| Foreign Exchange rate Adjustments | 124.90% | -78.81% | 1,780.00% | 119.80% | -161.78% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 272.76% | 577.68% | 88.90% | -100.07% | 37.36% |